Endosteal scalloping is the erosion or indentation of the inner surface of a bone’s cortex, visible on imaging studies such as X-rays, CT scans, and MRI. It shows up as a wavy or nibbled-away pattern along the inside wall of the bone, where a lesion has pressed against or eaten into the hard outer shell from within. The finding is common across a wide range of bone conditions, from completely harmless cartilage remnants to aggressive tumors, which is exactly what makes it both clinically useful and maddeningly ambiguous. Its depth, location, and the company it keeps on imaging are what allow radiologists and orthopedic oncologists to sort the benign from the dangerous.
The Anatomy Behind the Name
Bone is not solid all the way through. The hard outer shell, the cortex, encloses softer tissue inside: marrow, fat, blood-forming cells, and sometimes cartilage rests left over from skeletal development. The inner surface of the cortex is lined by a thin connective tissue layer called the endosteum, which houses the cells responsible for building and breaking down bone throughout life.1Royal Society Open Biology. Bone marrow endosteum in homeostasis and metastasis When something growing inside the bone pushes outward against that inner lining, it can thin or erode the cortex from within. That erosion pattern is what imaging captures as endosteal scalloping.
The degree of scalloping matters more than whether it exists at all. Radiologists typically describe it in terms of how much of the cortex thickness has been affected. Superficial scalloping, involving less than a third of the cortex, is much less worrying than deep scalloping that eats through more than two-thirds. That two-thirds threshold comes up repeatedly in the literature as a dividing line between lesions likely to be benign and those that warrant further workup or biopsy.
Why Cartilage Tumors Are the Main Event
The clinical scenario where endosteal scalloping gets the most attention is distinguishing enchondromas from chondrosarcomas. Enchondromas are benign islands of cartilage inside bone, present in a surprisingly large fraction of the adult population. Most are found incidentally on imaging done for unrelated reasons and never cause problems. Low-grade chondrosarcomas, on the other hand, are slow-growing malignant tumors of cartilage that can look very similar on imaging. Both produce the characteristic stippled or “rings and arcs” calcification pattern on X-ray and CT, and both can sit quietly inside bone for years. The stakes of getting the distinction wrong are high: an enchondroma needs nothing more than monitoring, while a chondrosarcoma typically needs surgery.
Endosteal scalloping is one of the most scrutinized features in this distinction. In a study from a reference center comparing enchondromas to atypical cartilaginous tumors (the modern term for what used to be called grade 1 chondrosarcoma), tumor size of 40 mm or greater and pronounced endosteal scalloping emerged as the key imaging features suggesting the more aggressive diagnosis.2Journal of Orthopaedic Reports. Imaging differences between enchondroma and atypical cartilaginous tumor: Insights from a reference center A separate study in European Radiology identified scalloping involving more than two-thirds of the cortex as one of the features that differentiated enchondromas from grade 1 chondrosarcomas, alongside pain, cortical destruction, bone expansion, and soft tissue mass.3PubMed. What are the differentiating clinical and MRI-features of enchondromas from low-grade chondrosarcomas?
The numbers paint a more complicated picture than “scalloping means cancer,” though. When researchers built a radiological scoring system for this exact distinction, endosteal scalloping on CT had very high sensitivity at about 97%, meaning it caught nearly all the chondrosarcomas. But the specificity was only around 30%, meaning it also flagged a large number of benign enchondromas.4PubMed Central. A Radiological Scoring System for Differentiation between Enchondroma and Chondrosarcoma In practical terms, the presence of endosteal scalloping is a red flag worth investigating, but by itself it is far from proof of malignancy.
When Scalloping Is Completely Normal
One of the most important things to understand about endosteal scalloping is that it does not always signal disease progression, even when a cartilage lesion is present. Enchondromas sitting at the edge of the medullary cavity, close to the inner cortex, almost always produce some degree of scalloping simply because of their position. A study of small eccentric chondromas in long bones found that every single one showed cortical scalloping, with the average involvement reaching about 75% of the cortex. All of the curetted lesions were histologically benign, with no signs of cellular atypia. The researchers concluded that the degree of scalloping in that setting reflected the tumor’s location against the endosteum rather than any aggressive biological behavior.5SpringerLink / Skeletal Radiology. Cortical scalloping and cortical penetration by small eccentric chondroid lesions in the long tubular bones: not a sign of malignancy?
In pediatric patients the same principle holds. Among children with enchondromas, endosteal scalloping was found only in patients whose lesions sat in a marginal position within the bone, roughly one in five cases in one series. None of those scalloping cases had associated periosteal reactions or other aggressive features.6PubMed Central. Imaging Aspects of Enchondromas in Pediatric Patients The takeaway is that a centrally located enchondroma that does not touch the cortex will not produce scalloping at all, and a peripherally located one will almost certainly produce some. Location within the bone, not tumor behavior, drives the finding in many cases.
Deep Scalloping and the Distinction That Matters
If some scalloping is expected in benign lesions, where does the line fall? The data from a large machine-learning study comparing enchondromas to atypical cartilaginous tumors makes the contrast stark. Among over a hundred enchondromas, 99% had no endosteal scalloping at all, and not a single one had deep scalloping. Among atypical cartilaginous tumors, only about 44% had no scalloping, while roughly 43% showed deep scalloping involving more than two-thirds of the cortex.7BioMedical Engineering OnLine. Machine learning vs. radiomics for discriminating atypical cartilaginous tumors from benign enchondromas on MRI Deep scalloping, then, is the version of the finding that should genuinely worry clinicians and patients. Superficial scalloping in an incidentally discovered cartilage lesion is much less concerning.
This depth-based distinction helps explain why the scoring system mentioned earlier gave endosteal scalloping just one point in the overall score used to differentiate enchondromas from chondrosarcomas.8PubMed Central. A Radiological Scoring System for Differentiation between Enchondroma and Chondrosarcoma On its own, the finding is a soft indicator. Combined with other features, like pain, a size above 4 to 5 cm, periosteal reaction, marrow edema around the lesion, and especially cortical destruction or soft tissue extension, it becomes a much more powerful piece of the puzzle. The researchers studying atypical cartilaginous tumors noted that these tumors’ deep scalloping and cortical remodeling allow them to expand more uniformly, producing a relatively spherical shape that differs from the lobulated look of a typical enchondroma.9BioMedical Engineering OnLine. Machine learning vs. radiomics for discriminating atypical cartilaginous tumors from benign enchondromas on MRI
Beyond Cartilage Tumors
Endosteal scalloping is not exclusive to cartilaginous lesions. It shows up in several other conditions, each with its own clinical context and implications.
Fibrous dysplasia, a developmental condition where normal bone is replaced by fibrous tissue and immature bone, can produce endosteal scalloping. The key feature radiologists rely on to keep fibrous dysplasia in the differential is that even when scalloping is present, the outer cortical contour stays smooth and intact.10PubMed Central. Fibrous dysplasia for radiologists: beyond ground glass bone matrix The characteristic “ground glass” appearance of the lesion on X-ray, combined with that smooth outer surface, is usually enough to identify it without biopsy.
Primary hyperparathyroidism, when severe, causes increased bone resorption on both the outer (subperiosteal) and inner (endosteal) surfaces of bone. In the most advanced form, called osteitis fibrosa cystica, the bone loss is generalized and can produce cystic lesions known as brown tumors, typically in long bones and the jaw.11PubMed Central. Solitary phalangeal brown tumour in primary hyperparathyroidism: Report of a rare presentation Unlike tumor-related scalloping, the endosteal changes in hyperparathyroidism tend to be diffuse rather than focal, and they reverse with treatment of the underlying hormonal excess.
Gaucher disease, a genetic condition in which lipid-laden cells accumulate in the bone marrow, leads to expansion of the marrow cavity and thinning of the cortex from within. The hallmark imaging findings include a flask-shaped deformity of the distal femur from medullary expansion, along with diffuse osteoporosis and a risk of bone infarcts and fractures.12PubMed Central. 99mTc-MDP Bone Scintigraphy in Gaucher Disease The endosteal erosion in Gaucher disease is driven by pressure from the expanding marrow contents rather than by a discrete mass.
Metastatic disease to bone represents the most dangerous end of the spectrum. Tumor cells that seed the bone marrow can stimulate excessive bone resorption, bone formation, or both, disrupting the normal remodeling balance.13PubMed Central. Bone metastasis: mechanisms and therapeutic opportunities The resulting skeletal destruction frequently includes cortical erosion from the endosteal side. In metastatic bone disease, the pattern of scalloping tends to be more irregular and destructive than what is seen with benign cartilage lesions, often accompanied by frank cortical breaks and periosteal reaction.
CT, MRI, and How Radiologists Measure It
Both CT and MRI can detect endosteal scalloping, and the agreement between the two modalities is reassuringly good. A direct comparison found that CT and MRI showed high agreement for evaluating deep endosteal scalloping, cortical expansion, cortical disruption, and soft tissue extension in central cartilaginous tumors. Both achieved roughly 92% accuracy against final histopathology, with strong agreement between different observers reading the same scans.14PubMed. Assessment of central cartilaginous tumor of the appendicular bone: inter-observer and intermodality agreement and comparison of diagnostic performance of CT and MRI
In practice, CT and MRI serve complementary roles. CT excels at showing the fine detail of cortical bone, so it is particularly good at revealing the extent of scalloping and any cortical breaks. MRI is better at characterizing the soft tissue components of a lesion, detecting marrow edema around a tumor, and showing whether a mass has extended beyond the bone. Many bone tumor centers use both when trying to determine whether a cartilage lesion needs surgery or can safely be monitored.
When Endosteal Scalloping Changes Treatment
For cartilage tumors in the appendicular skeleton, the treatment decision often hinges on the imaging pattern. Low-grade chondrosarcomas without aggressive radiological features, meaning no deep scalloping, no cortical destruction, and no soft tissue mass, can be treated with intralesional surgery, essentially scraping the tumor out from within the bone. This less invasive approach has shown good oncological outcomes with very low complication rates. Wide resection, the more aggressive operation that removes a segment of bone entirely, is reserved for cases where imaging shows clearly aggressive behavior.15PubMed Central. Surgical treatment of central grade 1 chondrosarcoma of the appendicular skeleton
Deep endosteal scalloping directly influences where a tumor falls on that decision spectrum. A cartilage lesion that is small, centrally located, and shows no scalloping at all is almost certainly an enchondroma and can be left alone with periodic imaging. A large lesion with deep scalloping, cortical thinning, and surrounding marrow edema has multiple features pushing toward biopsy and potential surgical treatment. The practical difference for a patient is substantial: monitoring with occasional imaging versus an operation, possible reconstruction, and the recovery that follows.
Fracture Risk and Structural Integrity
Beyond tumor classification, endosteal scalloping has implications for whether a bone is at risk of breaking. The cortex is the main load-bearing structure in long bones, and any process that thins it from the inside reduces the bone’s ability to withstand normal forces. This is relevant not just in primary bone tumors but especially in metastatic disease, where the question of whether a bone needs prophylactic surgical stabilization comes up frequently.
The Mirels scoring system, widely used to estimate fracture risk in bones with metastatic lesions, traditionally looks at the width of the bone involved by tumor. Some authors have argued that the severity of endosteal scalloping and cortical destruction is a more structurally meaningful way to score the “size” domain than simply measuring how much of the bone’s cross-section is occupied.16Elsevier / Operative Techniques in Orthopaedics. Diagnostic and Interventional Radiology Considerations in Metastatic Bone Disease The reasoning is straightforward: a lesion that has deeply undermined the cortex has done more structural damage than one that fills a large volume of marrow without affecting the cortical shell.
Machine Learning and the Future of Interpretation
One of the persistent challenges with endosteal scalloping is that its interpretation requires experience and judgment. Is the scalloping deep enough to warrant concern? Is it the location causing the appearance, or is the tumor genuinely aggressive? Radiologists with different levels of experience can reach different conclusions, and even among experts there is some variability.
Machine learning models are now being developed to help with this specific problem. Recent work has compared traditional radiomic analysis to machine-learning classifiers for distinguishing enchondromas from atypical cartilaginous tumors on MRI, using features including the presence and depth of endosteal scalloping as inputs.17BioMedical Engineering OnLine. Machine learning vs. radiomics for discriminating atypical cartilaginous tumors from benign enchondromas on MRI The goal is not to replace the radiologist’s eye but to flag cases where the combination of features, including scalloping depth, lesion size, shape, and signal characteristics, tips the probability toward the malignant side.
These tools remain in the research phase, but the need is real. Cartilage tumors are among the most common incidental bone findings on imaging, and most are benign. The ability to reliably stratify risk based on imaging alone would spare many patients from unnecessary biopsy procedures, while ensuring the ones who do need surgery are identified early. Endosteal scalloping, as one of the most visible and reproducible features on imaging, will likely be a key input variable in whatever diagnostic algorithms eventually reach clinical practice.
Common Misunderstandings Worth Correcting
Perhaps the most frequent misconception about endosteal scalloping is treating it as a binary indicator of malignancy. A patient who reads “endosteal scalloping present” on an imaging report and looks it up online can easily walk away terrified, because much of the accessible information discusses the finding in the context of chondrosarcoma. In reality, the finding by itself tells you that something inside the bone is pressing on or remodeling the inner cortex. That something could be a harmless cartilage rest in a position where it naturally contacts the cortex, a slowly expanding benign condition like fibrous dysplasia, or a metabolic process affecting the whole skeleton. Deep scalloping with additional aggressive features is a genuine concern; superficial scalloping in an incidentally discovered small lesion is usually not.
A related misunderstanding involves the assumption that a stable-looking lesion with scalloping is safe to ignore indefinitely. While most enchondromas do remain stable for life, the standard of care for lesions that show any scalloping is typically periodic follow-up imaging rather than a single “all clear.” Growth on serial imaging, increasing depth of scalloping, new pain, or the development of cortical disruption are all reasons to revisit the diagnosis. The monitoring interval depends on the clinical picture, but for an incidental cartilage lesion with mild scalloping, annual or biannual imaging for a few years is a common approach before extending the interval.
Finally, there is a tendency in older literature to treat the enchondroma-versus-chondrosarcoma question as though a clean line exists on imaging. Decades of research have made clear that no single imaging feature, including endosteal scalloping, provides a definitive answer. The best diagnostic accuracy comes from considering the full constellation of features, ideally with a multidisciplinary team that includes a musculoskeletal radiologist, an orthopedic oncologist, and a pathologist when biopsy material is available.18Journal of Orthopaedic Reports. Imaging differences between enchondroma and atypical cartilaginous tumor: Insights from a reference center Endosteal scalloping is one piece of evidence in that conversation, an important piece, but never the whole story.